XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Collaboration Revenue (Tables)
6 Months Ended
Jun. 30, 2020
Collaboration Agreements [Abstract]  
Summary of Changes in Balances of Contract Assets and Contract Liability

The following table presents changes during the six months ended June 30, 2020 in the balances of contract assets, including receivables from collaborative partners, and contract liabilities, including deferred revenue, as compared to what was disclosed in the Company’s 2019 Annual Report.

 

(in thousands)

 

Contract Assets

 

BALANCE - December 31, 2019

 

$

2,179

 

Additions for revenue recognized from billings

 

 

2,171

 

Deductions for cash collections

 

 

(1,521

)

BALANCE – June 30, 2020

 

$

2,829

 

 

 

 

 

 

(in thousands)

 

Contract Liabilities

 

BALANCE - December 31, 2019

 

$

23,579

 

Additions for advanced billings

 

 

2,171

 

Deductions for promised services provided in current period

 

 

(4,969

)

BALANCE – June 30, 2020

 

$

20,781

 

Summary of Collaboration Revenue

The following table summarizes the Company’s collaboration revenues for the periods indicated (in thousands).

 

 

 

For the Three Months

Ended June 30,

 

 

For the Six Months

Ended June 30,

 

(Dollars in thousands)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Collaboration Partner – Janssen

 

$

693

 

 

$

622

 

 

$

1,590

 

 

$

1,135

 

Collaboration Partner – Ultragenyx

 

 

913

 

 

 

2,544

 

 

 

1,824

 

 

 

3,932

 

Collaboration Partner – CureVac

 

 

231

 

 

 

3,409

 

 

 

540

 

 

 

5,303

 

Collaboration Partner – Other

 

 

485

 

 

 

3,578

 

 

 

1,014

 

 

 

4,133

 

Total collaboration revenue

 

$

2,322

 

 

$

10,153

 

 

$

4,968

 

 

$

14,503